Sign in

CIK 0001130598

  • Non-accelerated filer
  • Smaller reporting company

Traws Pharma, Inc.

Sign in to watch
Ticker
TRAW
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 267-759-3680
Business address
12 PENNS TRAIL, NEWTOWN, PA, 18940
Former names
Onconova Therapeutics, Inc., ONCONOVA THERAPEUTICS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-07-09 Dukes Iain D. Chief Executive Officer Grant or award · Stock Option (right to buy) +274,000 274,000
2026-03-08 Dukes Iain D. Chief Executive Officer Grant or award · Stock Option (right to buy) +231,336 231,336
2025-12-12 Dukes Iain D. Chief Executive Officer Grant or award +36,943 171,130
2025-12-12 Dukes Iain D. Chief Executive Officer Grant or award · Stock Option (right to purchase) +147,771 147,771
2025-10-12 Dukes Iain D. Chief Executive Officer Grant or award · Stock Option (right to purchase) +64,839 64,839
2024-04-01 Dukes Iain D. Executive Chairman Grant or award +67,500 134,187
2024-04-01 Dukes Iain D. Executive Chairman Grant or award +66,687 66,687
2024-04-01 Dukes Iain D. Executive Chairman Grant or award +67,550 134,187
2024-04-01 Dukes Iain D. Executive Chairman Grant or award +1,645,100 1,645,100
2024-04-01 Dukes Iain D. Executive Chairman Grant or award · Stock Option (right to purchase) +3,802,890 3,802,890
2024-04-01 Dukes Iain D. Executive Chairman Grant or award · Series C Preferred Stock +194.62 194.62
2024-04-01 Dukes Iain D. Executive Chairman Grant or award · Series C Preferred Stock +4,801.11 4,801.11

Page 1 of 1 · 12 trades